[Universal access, six years results in the Mexico City HIV/AIDS Program].
OBJECTIVE
To analyze the results of the Free Antiretroviral Medication Program of the Mexico City HIV/AIDS Program among the affected population in Mexico City.


METHODS
A retrospective analysis was conducted of medical attention, antiretroviral treatment and specialized laboratory results data from 2001 to 2006 from patients who sought services from the Mexico City HIV/AIDS Program.


RESULTS
Data from 5 146 patients who were undergoing ARV are presented. At the end of the period studied, 74% were current, 12.2% were not found for follow-up and 13.9% had died.


CONCLUSIONS
During the period evaluated, wider coverage was achieved in Mexico City as well as increased efficiency in ARV treatment and increased patient survival.
Soler Claudín
Carmen
C
Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México.
D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000191:economics / Q000600:supply & distribution / Q000627:therapeutic use*; D005260:Female; D005380:Financing, Government; D005500:Follow-Up Studies; D006078:Government Programs / Q000191:economics / Q000706:statistics & numerical data*; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006297:Health Services Accessibility / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008800:Mexico / Q000453:epidemiology; D008875:Middle Aged; D011320:Primary Health Care / Q000458:organization & administration / Q000706:statistics & numerical data; D015397:Program Evaluation; D012189:Retrospective Studies; D015996:Survival Rate / Q000639:trends; D014505:Urban Population; D055815:Young Adult
D019380:Anti-HIV Agents